All Practice Exams

Free Practice Questions for Lebanon Medical Colloquium

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Lebanese Healthcare Colloquium Licensing Examinations (MEHE / MOPH)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Exam Review

Key Facts: Lebanon Medical Colloquium Exam

180 MCQs

Written Exam Items

Official Medicine Colloquium papers

3 Hours

Written Exam Duration

Official Medicine Colloquium papers

12/20

Pass Mark (Written and Overall)

Decree No. 9276, Art. 5

2 Sessions

Annual Exam Sittings

DGHE Colloquium circulars

EN & FR

Official Delivery Languages

MEHE DGHE Regulations

MOPH License

Licensure Outcome

Lebanese Ministry of Public Health

The Lebanese Medical Colloquium is the national licensure examination required to obtain a practice licence from the Ministry of Public Health and register with the Lebanese Order of Physicians. Organised by MEHE/DGHE with MOPH and conducted by the Lebanese University Faculty of Medical Sciences, it comprises written, oral and clinical components under Decree No. 9276, which sets a 12/20 pass threshold. Recent official written papers carry 180 MCQs over 3 hours across internal medicine, surgery, pediatrics, OBGYN and public health. This bank offers 100 English-language study questions.

Sample Lebanon Medical Colloquium Practice Questions

Try these sample questions to review concepts for the Lebanon Medical Colloquium exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 58-year-old man presents to the emergency department with severe, crushing substernal chest pain radiating to his left shoulder and jaw that began 90 minutes ago while resting. His medical history includes hypertension, type 2 diabetes mellitus, and a 30 pack-year smoking history. Physical examination reveals blood pressure of 138/86 mmHg, heart rate of 92 bpm, and clear lung fields bilaterally. An emergent 12-lead electrocardiogram demonstrates 3 mm ST-segment elevation in leads II, III, and aVF with reciprocal ST depression in leads I and aVL. The hospital has an on-site catheterization laboratory currently staffed and operational. In addition to sublingual nitroglycerin and loading doses of aspirin and a P2Y12 inhibitor, what is the most appropriate next step in management?
A.Immediate intravenous unfractionated heparin bolus with serial cardiac troponin measurements at 0, 1, and 3 hours before intervention
B.Administration of intravenous tenecteplase followed by routine transfer to the intensive cardiac care unit
C.Immediate emergent primary percutaneous coronary intervention (PCI) with a goal door-to-balloon time within 90 minutes
D.Urgent coronary computed tomography angiography (CCTA) to evaluate the anatomical extent of coronary plaque rupture
Explanation: The patient presents with an acute inferior ST-segment elevation myocardial infarction (STEMI) presenting within 12 hours of symptom onset. According to current ACC/AHA and ESC myocardial infarction guidelines, primary percutaneous coronary intervention (PCI) is the gold standard reperfusion strategy when it can be performed in a timely fashion (door-to-balloon time <= 90 minutes at a PCI-capable center, or first medical contact-to-balloon time <= 120 minutes if transferred). Fibrinolysis is indicated only when primary PCI cannot be accomplished within 120 minutes of STEMI diagnosis.
2A 64-year-old woman with a history of anterior wall myocardial infarction 6 months ago returns for a routine follow-up. She reports persistent dyspnea on exertion when climbing one flight of stairs (NYHA functional class II) and mild bilateral pedal edema. Transthoracic echocardiography reveals a left ventricular ejection fraction of 32% with anterior and apical hypokinesis. Her current medications are lisinopril 20 mg daily, carvedilol 25 mg twice daily, and furosemide 40 mg daily. Her blood pressure is 124/76 mmHg, heart rate is 68 bpm, serum potassium is 4.2 mEq/L, and estimated glomerular filtration rate (eGFR) is 58 mL/min/1.73 m². According to contemporary guidelines for heart failure with reduced ejection fraction (HFrEF), which addition to her medical regimen has proven mortality benefit?
A.Addition of spironolactone and an SGLT2 inhibitor (such as dapagliflozin or empagliflozin)
B.Addition of digoxin 0.25 mg daily to improve myocardial contractility
C.Addition of amlodipine 10 mg daily for afterload reduction
D.Addition of isosorbide dinitrate monotherapy
Explanation: Guideline-directed medical therapy (GDMT) for heart failure with reduced ejection fraction (HFrEF; LVEF <= 40%) consists of four foundational pillar medication classes that improve survival: (1) an ARNI (sacubitril/valsartan) or ACEi/ARB, (2) an evidence-based beta-blocker (carvedilol, metoprolol succinate, or bisoprolol), (3) a mineralocorticoid receptor antagonist (MRA, such as spironolactone or eplerenone), and (4) a sodium-glucose cotransporter-2 (SGLT2) inhibitor (dapagliflozin or empagliflozin). Because the patient is already receiving lisinopril and carvedilol, adding spironolactone (with K+ < 5.0 and eGFR > 30) and an SGLT2 inhibitor provides substantial further reductions in cardiovascular mortality and heart failure hospitalizations.
3A 72-year-old man presents to the emergency department with sudden-onset palpitations, lightheadedness, and shortness of breath that began 45 minutes ago. Physical examination reveals an irregularly irregular pulse with a heart rate of 165 bpm, blood pressure of 78/48 mmHg, diaphoresis, and cold clammy extremities. Jugular venous distension is noted, and pulmonary auscultation reveals bibasilar crackles. An ECG confirms atrial fibrillation with rapid ventricular response. What is the most appropriate initial management?
A.Intravenous diltiazem bolus followed by a continuous infusion
B.Immediate synchronized electrical cardioversion
C.Intravenous amiodarone 150 mg infused over 10 minutes
D.Intravenous metoprolol 5 mg administered every 5 minutes up to 3 doses
Explanation: Any tachyarrhythmia (including atrial fibrillation with rapid ventricular response) associated with hemodynamic instability—manifested by hypotension (BP 78/48 mmHg), acute altered mental status, ischemic chest discomfort, acute heart failure, or signs of hypoperfusion shock—mandates immediate synchronized electrical cardioversion under appropriate procedural sedation if feasible. Pharmacotherapy takes longer to act and may worsen hypotension.
4A 78-year-old man presents to the clinic with exertional lightheadedness and an episode of syncope while climbing stairs yesterday. Over the past 4 months, he has also experienced exertional chest tightness and progressive dyspnea. Physical examination reveals a slow-rising, low-amplitude carotid pulse (pulsus parvus et tardus) and a harsh, late-peaking crescendo-decrescendo systolic murmur heard loudest at the right second intercostal space that radiates to both carotid arteries. The second heart sound (S2) is soft and single. Which of the following is the most likely diagnosis?
A.Aortic regurgitation
B.Hypertrophic cardiomyopathy
C.Mitral regurgitation
D.Severe aortic stenosis
Explanation: The patient exhibits the classic clinical triad of severe aortic stenosis: angina, syncope, and heart failure symptoms (dyspnea). Physical examination findings characteristic of severe aortic stenosis include a delayed and weakened carotid pulse upstroke (pulsus parvus et tardus), a harsh crescendo-decrescendo systolic ejection murmur best heard at the right upper sternal border radiating into the carotid arteries, and a diminished or absent aortic component of the second heart sound (soft/single S2). In elderly patients, the most common etiology is age-related calcific degeneration of a trileaflet aortic valve.
5A 24-year-old woman with a history of persistent asthma presents to the emergency department with severe acute dyspnea, tachypnea, and chest tightness. She has used her albuterol inhaler 8 times over the last 3 hours without relief. On examination, she is sitting upright in a tripod position, speaking in short, single-word phrases. Her vital signs are: respiratory rate 34 breaths/min, heart rate 128 bpm, blood pressure 132/84 mmHg, and SpO2 89% on room air. Auscultation reveals diffuse bilateral expiratory and inspiratory wheezing with marked intercostal retractions. In addition to high-flow supplemental oxygen, what is the most appropriate initial pharmacological management?
A.Nebulized hypertonic saline and intravenous broad-spectrum antibiotics
B.Subcutaneous epinephrine injection with inhaled budesonide and intravenous aminophylline
C.Repetitive or continuous nebulized short-acting beta-2 agonist (albuterol) combined with inhaled ipratropium bromide plus early systemic corticosteroids
D.Immediate endotracheal intubation followed by administration of intravenous methylprednisolone alone
Explanation: According to Global Initiative for Asthma (GINA) guidelines, first-line medical therapy for a severe acute asthma exacerbation includes supplemental oxygen to maintain SpO2 93-95%, repetitive or continuous nebulized short-acting beta-2 agonists (SABA, e.g., albuterol), inhaled short-acting muscarinic antagonist (SAMA, ipratropium bromide, which reduces hospitalization risk when added to SABA in severe exacerbations), and early administration of systemic corticosteroids (oral prednisone or IV methylprednisolone) to accelerate resolution of airway inflammation and reduce relapse.
6A 68-year-old man with severe chronic obstructive pulmonary disease (COPD, GOLD Stage III) presents with a 3-day history of worsening shortness of breath, increased sputum production, and a change in sputum character from clear to dark green and purulent. On examination, he is tachypneic at 26 breaths/min, heart rate is 96 bpm, and room air SpO2 is 84%. Auscultation reveals diffuse expiratory wheezing and coarse rhonchi. What is the target oxygen saturation range for controlled supplemental oxygen therapy in this patient, and which pharmacotherapy is indicated according to the Anthonisen criteria?
A.Target SpO2 88–92%; initiate systemic corticosteroids, short-acting bronchodilators, and empiric antibiotics
B.Target SpO2 98–100%; initiate high-dose inhaled corticosteroids and prophylactic macrolide monotherapy without systemic steroids
C.Target SpO2 94–98%; initiate oral theophylline, intravenous loop diuretics, and empiric antifungal therapy
D.Target SpO2 80–84%; initiate non-invasive ventilation immediately without pharmacological intervention
Explanation: In acute exacerbations of COPD (AECOPD), controlled oxygen therapy should target an SpO2 of 88-92% (or PaO2 60-70 mmHg) via Venturi mask or nasal cannula to prevent worsening hypercapnic respiratory failure from loss of hypoxic vasoconstriction, Haldane effect, and increased dead space ventilation. Furthermore, this patient meets all three Anthonisen criteria (Type 1 exacerbation: worsening dyspnea, increased sputum volume, and increased sputum purulence), which strongly predicts bacterial involvement and justifies empiric antibiotics (e.g., amoxicillin-clavulanate, azithromycin, or a respiratory fluoroquinolone) in conjunction with systemic corticosteroids (prednisone 40 mg daily for 5 days) and inhaled short-acting bronchodilators.
7A 52-year-old woman presents to the emergency department with sudden-onset pleuritic right-sided chest pain and dyspnea that started 2 hours ago. She underwent an uncomplicated left total knee arthroplasty 10 days ago. Her vital signs are: blood pressure 82/50 mmHg, heart rate 124 bpm, respiratory rate 28 breaths/min, and SpO2 88% on ambient air. Bedside echocardiography demonstrates acute right ventricular dilation, McConnell's sign (hypokinesia of the RV free wall with normal apical contractility), and severe tricuspid regurgitation. An emergent bedside CT pulmonary angiography is considered, but the patient remains persistently hypotensive despite an initial 500 mL crystalloid bolus. What is the most appropriate next step in management?
A.Immediate administration of full-dose low-molecular-weight heparin (LMWH) and transfer to the general medical ward
B.Immediate intravenous systemic thrombolytic therapy (e.g., recombinant tissue plasminogen activator [rtPA])
C.Emergent placement of an inferior vena cava (IVC) filter without medical anticoagulation
D.Immediate oral rivaroxaban 15 mg twice daily and observation for 24 hours
Explanation: The patient presents with high-risk (massive) pulmonary embolism, defined by confirmed or suspected PE accompanied by hemodynamic instability (systolic blood pressure < 90 mmHg or vasopressor requirement) and acute right ventricular dysfunction. According to ESC and ACCP guidelines, high-risk PE with hemodynamic collapse warrants immediate systemic thrombolysis (e.g., alteplase 100 mg IV over 2 hours) or surgical/catheter-directed embolectomy if thrombolysis is contraindicated, along with unfractionated heparin (UFH). Systemic thrombolysis rapidly lyses the thromboembolism, reduces right ventricular afterload, and restores systemic perfusion.
8A 74-year-old man is brought to the emergency clinic by his daughter because of fever, productive cough with rust-colored sputum, and progressive confusion over the past 36 hours. His past medical history is notable for hypertension and benign prostatic hyperplasia. On examination, he is disoriented to time and place. Vital signs: temperature 38.9°C, blood pressure 86/54 mmHg, heart rate 112 bpm, and respiratory rate 32 breaths/min. Laboratory analysis reveals a blood urea nitrogen (BUN) of 28 mg/dL (10 mmol/L) and a serum sodium of 134 mEq/L. Chest radiography demonstrates right lower lobe consolidation with air bronchograms. Calculating his CURB-65 score, what is the most appropriate management setting and initial empiric antibiotic regimen?
A.CURB-65 score of 3; ward admission with oral amoxicillin-clavulanate plus clarithromycin once he is clinically stable
B.CURB-65 score of 1; outpatient management with oral amoxicillin monotherapy for 5 days
C.CURB-65 score of 5; urgent inpatient hospital admission with intensive care assessment, and intravenous ceftriaxone plus azithromycin (or an intravenous respiratory fluoroquinolone)
D.CURB-65 score of 2; outpatient management with oral doxycycline and close 48-hour telephonic follow-up
Explanation: The CURB-65 score assigns 1 point each for: Confusion (present = 1), Urea > 7 mmol/L (equivalently BUN > about 19-20 mg/dL; here 28 mg/dL / 10 mmol/L = 1), Respiratory rate >= 30/min (32/min = 1), Blood pressure systolic < 90 mmHg or diastolic <= 60 mmHg (86/54 mmHg = 1), and Age >= 65 years (74 years = 1). This patient meets all five criteria, giving a maximum score of 5. A CURB-65 score of 3-5 indicates severe community-acquired pneumonia (CAP) with high 30-day mortality (roughly 15-40%), requiring urgent inpatient admission, assessment for intensive care, and broad-spectrum parenteral therapy: a beta-lactam (e.g., ceftriaxone or ampicillin-sulbactam) plus a macrolide (azithromycin), or an intravenous respiratory fluoroquinolone such as levofloxacin.
9A 56-year-old man with decompensated alcoholic cirrhosis presents with worsening abdominal distension, mild diffuse abdominal tenderness, and a low-grade fever of 38.1°C over the past 24 hours. He is alert but sluggish. Diagnostic paracentesis is performed, yielding cloudy ascitic fluid. Ascitic fluid analysis reveals: total white blood cell count 620/mm³ with 78% polymorphonuclear leukocytes (absolute neutrophil count 484/mm³), total protein 1.1 g/dL, glucose 64 mg/dL, and lactate dehydrogenase (LDH) 82 U/L. Serum albumin is 2.4 g/dL and ascitic albumin is 0.6 g/dL. What is the most appropriate management for this patient?
A.Diagnose chylous ascites; initiate medium-chain triglyceride diet and perform serial large-volume paracentesis without antibiotics
B.Diagnose secondary bacterial peritonitis; order emergent exploratory laparotomy and start oral metronidazole monotherapy
C.Diagnose peritoneal carcinomatosis; withhold antibiotics until fungal and mycobacterial cultures return in 4 weeks
D.Diagnose spontaneous bacterial peritonitis (SBP); initiate intravenous cefotaxime (or ceftriaxone) and intravenous 20% human albumin (1.5 g/kg on day 1 and 1 g/kg on day 3)
Explanation: Spontaneous bacterial peritonitis (SBP) is diagnosed when the ascitic fluid absolute neutrophil count (ANC) is >= 250/mm³ (here, 484/mm³) in the absence of an intra-abdominal surgically treatable infection source. First-line empiric antibiotic therapy is an intravenous third-generation cephalosporin (cefotaxime 2 g IV every 8h or ceftriaxone 2 g IV daily). In addition, intravenous albumin infusion (1.5 g/kg body weight within 6 hours of diagnosis, followed by 1.0 g/kg on day 3) is a guideline-mandated intervention that significantly reduces the incidence of hepatorenal syndrome and reduces overall mortality from ~30% to < 10%.
10A 50-year-old man with chronic hepatitis C cirrhosis presents to the emergency department with sudden, massive hematemesis and melena. On examination, he is pale and diaphoretic. Vital signs: blood pressure 88/52 mmHg, heart rate 122 bpm, respiratory rate 22 breaths/min. Intravenous access is secured with two large-bore peripheral cannulae, and volume resuscitation is initiated with crystalloids. A restrictive transfusion strategy is planned with a target hemoglobin of 7–8 g/dL. Which pharmacologic regimen should be initiated immediately before urgent upper endoscopy, and what is the definitive endoscopic procedure of choice?
A.Intravenous pantoprazole monotherapy; endoscopic sclerotherapy with ethanolamine oleate
B.Intravenous octreotide (somatostatin analog) and prophylactic intravenous ceftriaxone; endoscopic variceal band ligation (EVL)
C.Intravenous vasopressin monotherapy; balloon tamponade with a Sengstaken-Blakemore tube as first-line therapy
D.Oral propranolol 40 mg twice daily; transjugular intrahepatic portosystemic shunt (TIPS) within 1 hour
Explanation: In acute upper gastrointestinal bleeding secondary to suspected or confirmed ruptured esophageal varices, the immediate medical management consists of: (1) cautious hemodynamic resuscitation (targeting systolic BP 90-100 mmHg and hemoglobin 7-8 g/dL), (2) early initiation of vasoactive drugs (octreotide IV 50 mcg bolus followed by 50 mcg/h infusion, or terlipressin) to induce splanchnic vasoconstriction and decrease portal venous inflow, and (3) prophylactic antibiotics (intravenous ceftriaxone 1 g daily for up to 7 days), which significantly reduce bacterial translocation, recurrent bleeding, and in-hospital mortality. Urgent upper endoscopy within 12 hours with endoscopic variceal ligation (EVL) is the gold standard procedure for achieving definitive hemostasis.

About the Lebanon Medical Colloquium Exam

The Lebanon Medical Colloquium (Colloque de Médecine Générale / امتحان الكولوكيوم في الطب العام) is the national licensing examination that medical graduates must pass to practise medicine in Lebanon. Decree No. 9276 of 5 October 1996 applies it to holders of a general-medicine degree from faculties and institutes operating in Lebanon and abroad without exception, and sets its three components: a written, an oral and a clinical examination. It is organised by the Ministry of Education and Higher Education (MEHE) with the Ministry of Public Health (MOPH), and conducted by the Lebanese University Faculty of Medical Sciences. Recent official papers set the written test at 180 multiple-choice questions over 3 hours, evaluating diagnostic reasoning and patient management in internal medicine, general surgery, pediatrics, obstetrics and gynecology, and preventive health. The 2026 Directorate General of Higher Education notice confirmed that Colloquium examinations are held in French or English only. This bank is an independent English-language MCQ study adaptation by OpenExamPrep.

Exam sponsor: Directorate General of Higher Education (MEHE) & Ministry of Public Health (MOPH) in coordination with the Lebanese Order of Physicians (LOP). The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The Lebanese Medical Colloquium runs in two sessions per year (a first and a second session) whose dates are fixed by Directorate General of Higher Education circulars; for 2026, first-session applications were accepted from 2 March to 15 June 2026. It is organised by the Ministry of Education and Higher Education together with the Ministry of Public Health, with the Lebanese University Faculty of Medical Sciences conducting the examinations (Decree No. 9276, Art. 4). Under Art. 5 of that decree the Colloquium in general medicine comprises a written, an oral and a clinical examination; recent official papers set the written test at 180 machine-scored MCQs over 3 hours, covering internal medicine, surgery, pediatrics, obstetrics and gynecology, and public health/pharmacology. Decree No. 9276 applies the Colloquium to graduates of faculties operating in Lebanon and abroad without exception. This practice bank provides 100 English-language study questions adapted to the core medical disciplines tested on the examination.

Time Limit

3 hours (180 minutes) for the written paper on recent official papers; oral and clinical examinations are held on separately scheduled dates

Passing Score

Decree No. 9276 (Art. 5): at least 12/20 on the written paper to sit the oral and clinical examinations, at least 12/20 overall across the three components, and not less than 8/20 on the clinical examination

Exam / Certification Fees

A lump-sum registration fee fixed by decree taken in the Council of Ministers; the amount is not published in the statute. MEHE launched electronic payment of Colloquium fees in July 2026, and the 2026 notice required payment within one week of application acceptance

Exam sponsor website

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

30%

Internal Medicine & Subspecialties

Cardiovascular, pulmonary, gastrointestinal, renal, endocrine, infectious, neurological, rheumatologic, and hematologic disease diagnosis and therapy.

20%

General Surgery & Surgical Emergencies

Evaluation of acute abdomen, trauma initial assessment, shock types and management, perioperative monitoring, and surgical wound care.

20%

Pediatrics & Neonatology

Pediatric developmental milestones, vaccination schedules, neonatal jaundice, pediatric infectious diseases, and pediatric fluid resuscitation.

15%

Obstetrics & Gynecology

Routine antenatal care, labor complications, preeclampsia, postpartum hemorrhage management, family planning, and gynecologic oncology screening.

15%

Public Health, Pharmacology & Medical Ethics

Preventive medicine, biostatistics and epidemiology, mechanism-based pharmacotherapy, clinical toxicology, and medical ethics.

Preparing for the Lebanon Medical Colloquium Exam

What You Need to Know

  • Passing score: Decree No. 9276 (Art. 5): at least 12/20 on the written paper to sit the oral and clinical examinations, at least 12/20 overall across the three components, and not less than 8/20 on the clinical examination
  • Assessment: The Lebanese Medical Colloquium runs in two sessions per year (a first and a second session) whose dates are fixed by Directorate General of Higher Education circulars; for 2026, first-session applications were accepted from 2 March to 15 June 2026. It is organised by the Ministry of Education and Higher Education together with the Ministry of Public Health, with the Lebanese University Faculty of Medical Sciences conducting the examinations (Decree No. 9276, Art. 4). Under Art. 5 of that decree the Colloquium in general medicine comprises a written, an oral and a clinical examination; recent official papers set the written test at 180 machine-scored MCQs over 3 hours, covering internal medicine, surgery, pediatrics, obstetrics and gynecology, and public health/pharmacology. Decree No. 9276 applies the Colloquium to graduates of faculties operating in Lebanon and abroad without exception. This practice bank provides 100 English-language study questions adapted to the core medical disciplines tested on the examination.
  • Time limit: 3 hours (180 minutes) for the written paper on recent official papers; oral and clinical examinations are held on separately scheduled dates
  • Exam / certification fees: A lump-sum registration fee fixed by decree taken in the Council of Ministers; the amount is not published in the statute. MEHE launched electronic payment of Colloquium fees in July 2026, and the 2026 notice required payment within one week of application acceptance Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Lebanon Medical Colloquium: Suggested Study Strategy

1Focus heavily on clinical case presentations and diagnostic algorithms for common acute emergencies in internal medicine and surgery.
2Review pediatric immunization timelines, developmental milestones, and weight-based emergency medication dosing.
3Practice high-yield OBGYN management protocols, especially hypertensive disorders of pregnancy and postpartum hemorrhage management.
4Pay attention to precision with machine-readable sheets: use 2B/HB pencils only, as ink pens cannot be scanned by the automated grading machines.

Frequently Asked Questions

What is the format of the Lebanese Medical Colloquium examination?

Decree No. 9276 (Art. 5) sets three components for general medicine: a written examination, an oral examination and a clinical examination. Recent official papers put the written test at 180 multiple-choice questions over 3 hours on machine-readable answer sheets. Only candidates scoring at least 12/20 on the written paper may sit the oral and clinical examinations.

Who is required to take the Lebanon Medical Colloquium?

Decree No. 9276 (Art. 5) subjects holders of a general-medicine degree from faculties and institutes operating in Lebanon and abroad, without exception, to the Colloquium before they may be licensed to practise (permis d'exercer) by the Ministry of Public Health. Degrees obtained by correspondence study are not admitted to the examination. Candidates who graduated abroad apply directly to the DGHE, while graduates of private institutions inside Lebanon apply through their university delegate.

In what languages is the Lebanese Medical Colloquium administered?

The official examination is offered in English and French, corresponding to the language of instruction of the candidate's medical school. This OpenExamPrep question bank provides an English-language study adaptation designed to help candidates prepare for the core clinical concepts tested on the exam.

How often are Colloquium sessions held in Lebanon?

The Directorate General of Higher Education runs two sessions per year, announced as the first session (الدورة الأولى) and the second session (الدورة الثانية). Exact dates are fixed by circular rather than by fixed calendar months: for 2026, first-session applications were accepted from 2 March to 15 June 2026, with university-equivalency files due by 30 April 2026.

How are exam fees paid for the 2026 Colloquium?

Candidates apply through the DGHE Colloquium portal and pay the statutory registration fee within one week of their application being accepted. MEHE announced the move of Colloquium services to electronic fee payment in July 2026. The fee amount is fixed by decree rather than published in the pharmacy and medicine practice laws themselves, so candidates should confirm the current figure on the DGHE notice.